跳至主要内容
临床试验/ISRCTN81931394
ISRCTN81931394已完成未知

An unblinded, two-arm randomised controlled trial to determine the effectiveness and cost-effectiveness of antimicrobial impregnated (with rifampicin and miconazole) long lines (termed peripherally inserted central venous catheters, or AM-PICC) compared with standard PICC (S-PICC) for reducing blood stream infection (BSI)

Great Ormond Street Hospital for Children NHS Foundation Trust (UK)0 个研究点目标入组 861 人开始时间: 2014年11月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
861

研究概览

简要总结

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31040096 (added 02/05/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Babies who require a PICC (Premicath 1 Fr)
  • 2. Admitted to a NNU that is recruiting for this trial
  • 3. Parent/legal representative of the baby gives informed written consent for the trial
  • Note: Babies with the following can be included in the trial:
  • 1. Congenital malformations
  • 2. Gastrointestinal surgical conditions
  • 3. Previous PICC (non-trial PICC)
  • 4. Previously treated BSI which has resolved in the opinion of the Investigator

排除标准

  • 1. Baby has been previously entered into this trial
  • 2. Baby has a known allergy or hypersensitivity to rifampicin or miconazole

研究者

相似试验